Class I recall for Siemens bacterial infection tests

Siemens Healthcare Diagnostics' Rapid Gram Negative Combo Panels measuring bacteria to determine antibiotic treatment are under a Class I recall from the FDA. The agency said the tests, which are meant to identify certain gram negative bacteria and measure how these bacteria respond to antibiotics to help healthcare providers select the correct treatment for a patient, are inaccurately reporting certain bacteria as sensitive to certain antibiotics when they are in fact resistant. The incorrect test results relate to these antibiotics: Aztreonam, Cefotaxime, Ceftazidime, and Ceftriaxone. The tests were recalled because they can cause ineffective treatment and, in rare instances, may contribute to death. Safety Alert

Suggested Articles

By employing heart rate signals, physical activity and sleep quality, common Fitbit trackers may be able to predict the spread of the flu.

Nanox has raised $26 million to help fuel the development and commercialization of its "Star Trek"-inspired digital X-ray bed.

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.